Sarepta Therapeutics
SRPT
#4401
Rank
NZ$4.03 B
Marketcap
NZ$38.53
Share price
-2.45%
Change (1 day)
-82.05%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$6.04 Billion

According to Sarepta Therapeutics 's latest financial reports the company's total assets are NZ$6.04 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Sarepta Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$7.02 B36.13%
2023-12-31NZ$5.16 B4.77%
2022-12-31NZ$4.92 B6.91%
2021-12-31NZ$4.60 B11.41%
2020-12-31NZ$4.13 B52.83%
2019-12-31NZ$2.70 B10.56%
2018-12-31NZ$2.44 B32.92%
2017-12-31NZ$1.84 B200.8%
2016-12-31NZ$0.61 B53.06%
2015-12-31NZ$0.40 B6.23%
2014-12-31NZ$0.37 B6.13%
2013-12-31NZ$0.35 B42.39%
2012-12-31NZ$0.24 B257.71%
2011-12-31NZ$69.66 M16.89%
2010-12-31NZ$59.59 M-27.89%
2009-12-31NZ$82.64 M87.81%
2008-12-31NZ$44 M-12.76%
2007-12-31NZ$50.44 M-13.04%
2006-12-31NZ$58 M-29.72%
2005-12-31NZ$82.52 M106.49%
2004-12-31NZ$39.96 M-44.89%
2003-12-31NZ$72.52 M32.7%
2002-12-31NZ$54.65 M-32.88%
2001-12-31NZ$81.43 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
NZ$101.32 B 1,575.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$2.04 B-66.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
NZ$3.69 B-38.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$0.77 B-87.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$8.39 B 38.88%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
NZ$4.57 B-24.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
NZ$4.08 B-32.42%๐Ÿ‡บ๐Ÿ‡ธ USA